首页 | 本学科首页   官方微博 | 高级检索  
检索        


Incorporating potency into EU classification for carcinogenicity and reproductive toxicity
Authors:C Hennes  M Batke  W Bomann  S Duhayon  K Kosemund  V Politano  S Stinchcombe  J Doe
Institution:1. ECETOC AISBL, Avenue E. van Nieuwenhuyse 2 Bte 8, Brussels B-1160, Belgium;2. Fraunhofer Institute for Toxicology & Experimental Medicine, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany;3. Bayer CropScience AG, Alfred-Nobel-Straße 50, D-40789 Monheim/Rhein, Germany;4. Total Research and Technology Feluy, Zone Industrielle Feluy C, 7181 Seneffe, Belgium;5. Procter & Gamble Service GmbH, Berliner Allee 65, 64295 Darmstadt, Germany;6. Research Institute for Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA;g Product Safety, Regulations, Toxicology and Ecology, BASF SE, GUP/PP – Z470, 67056 Ludwigshafen, Germany;h Parker Doe Partnership LLP, PO Box 139, Frodsham, Cheshire WA6 1AZ, United Kingdom
Abstract:Although risk assessment, assessing the potential harm of each particular exposure of a substance, is desirable, it is not feasible in many situations. Risk assessment uses a process of hazard identification, hazard characterisation, and exposure assessment as its components. In the absence of risk assessment, the purpose of classification is to give broad guidance (through the label) on the suitability of a chemical in a range of use situations. Hazard classification in the EU is a process involving identification of the hazards of a substance, followed by comparison of those hazards (including degree of hazard) with defined criteria. Classification should therefore give guidance on degree of hazard as well as hazard identification. Potency is the most important indicator of degree of hazard and should therefore be included in classification. This is done for acute lethality and general toxicity by classifying on dose required to cause the effect. The classification in the EU for carcinogenicity and reproductive toxicity does not discriminate across the wide range of potencies seen (6 orders of magnitude) for carcinogenicity and for developmental toxicity and fertility. Therefore potency should be included in the classification process. The methodology in the EU guidelines for classification for deriving specific concentration limits is a rigorous process for assigning substances which cause tumours or developmental toxicity and infertility in experimental animals to high, medium or low degree of hazard categories by incorporating potency. Methods are suggested on how the degree of hazard so derived could be used in the EU classification process to improve hazard communication and in downstream risk management.
Keywords:C&  L  Classification and Labelling  CLP  Classification and Labelling and Packaging Regulations  CMR  carcinogenicity  mutagenicity and reproductive toxicity  D/RT  developmental/reproductive toxicity  EC  European Community  ECETOC  European Centre for Ecotoxicology and Toxicology of Chemicals  ECHA  European Chemicals Agency  ED10  dose calculated to cause an increase incidence of 10% of a response  EPA  United States Environmental Protection Agency  EU  European Union  GHS  United Nations Globally Harmonized System of Classification and Labelling of Chemicals  IRIS  EPA&rsquo  s Integrated Risk Information System  LOAEL  Lowest Observable Adverse Effect Level  NOAEL  No Observable Adverse Effect Level  SCL  specific concentration limit for presence of a CMR in a mixture  STOT  specific target organ toxicity  STOT-RE  specific target organ toxicity for repeat exposure  STOT-SE  specific target organ toxicity for single exposure  T25  the dose giving a tumour incidence of 25% in experimental animals after correction for the spontaneous incidence  TCDD  2  3  7  8-tetrachlorodibenzodioxin  TD50  the dose calculated to cause an increased incidence of tumours over background of 50%
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号